ASSOCIATION D'UN ANTICORPS ANTI-CD20 ET D'UN INHIBITEUR SELECTIF DE LA PI3 KINASE

• 收藏
• 分享

专利权人:

TG THERAPEUTICS, INC.;RHIZEN PHARMACEUTICALS SA;LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

发明人:

WEISS, MICHAEL,MISKIN, HARI,SPORTELLI, PETER,VAKKALANKA, SWAROOP K.V.S.

申请号：

CA2890176

公开号：

CA2890176A1

申请日:

2013.11.01

申请国别(地区):

CA

年份:

2014

代理人:

摘要：

Highly effective combinations of a compound of formula A (a PI3Kd selective inhibitor) and anti-CD20 antibodies are provided herein for the treatment and amelioration of PI3Kd and/or CD20 mediated diseases and disorderes. In particular, the combination can be used to treat cancers and autoimmune diseases. More particularly, the invention provided for a combination of a compound of formula A, or stereoisomers thereof, and ublituximab for the treatment and/or amerioration of hematological malignancies such as leukemia and lymphoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/